PNC Financial Services Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
PNC Financial Services Group's ALT Position: Q3 2026 in Review
PNC Financial Services Group reduced its Altimmune (ALT) stake by 45% in Q3 2026, selling an estimated $5.37K and leaving 2,109 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #4425.
PNC Financial Services Group first reported a position in ALT in Q4 2020 and has held it in 24 quarters since. The position peaked at $22.5K in Q1 2024. 130 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- PNC Financial Services Group held 2,109 shares of Altimmune worth $6.03K as of Q3 2026.
- PNC Financial Services Group sold 1,751 Altimmune shares in Q3 2026, an estimated $5.37K.
- Altimmune made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4425 holding.
- PNC Financial Services Group first reported a position in Altimmune in Q4 2020 and has held it in 24 quarters since.
- PNC Financial Services Group's Altimmune position peaked at $22.5K in Q1 2024.
- 130 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.